CL.CN
Cresco Labs Inc
Price:  
1.10 
CAD
Volume:  
31,826.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CL.CN Relative Valuation

-815.6%
Upside

As of 2026-09-25, the Relative Valuation of Cresco Labs Inc (CL.CN) is (7.87) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.10 CAD, the upside of Cresco Labs Inc based on Relative Valuation is -815.6%.

The range of the Relative Valuation is (8.68) - (6.27) CAD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 31.0x - 37.4x 34.2x
Forward P/E multiples 21.7x - 22.4x 22.0x
Fair Price (8.68) - (6.27) (7.87)
Upside -888.7% - -669.9% -815.6%
1.10 CAD
Stock Price
(7.87) CAD
Fair Price

CL.CN Relative Valuation - Historical P/E Data

Date P/E
2026-09-23 -3.93
2026-09-22 -3.97
2026-09-21 -3.68
2026-09-18 -3.75
2026-09-17 -3.64
2026-09-16 -3.64
2026-09-15 -3.64
2026-09-14 -3.72
2026-09-11 -3.57
2026-09-10 -3.61
2026-09-09 -3.72
2026-09-08 -3.79
2026-09-04 -3.86
2026-09-03 -3.68
2026-09-02 -3.89
2026-09-01 -3.72
2026-08-31 -3.86
2026-08-28 -3.86
2026-08-27 -3.64
2026-08-26 -3.64
2026-08-25 -3.79
2026-08-24 -3.86
2026-08-21 -4.04
2026-08-20 -3.86
2026-08-19 -4.00
2026-08-18 -3.68
2026-08-17 -3.86
2026-08-14 -3.93
2026-08-13 -3.93
2026-08-12 -3.79
2026-08-11 -3.86
2026-08-10 -3.64
2026-08-07 -3.75
2026-08-06 -3.64
2026-08-05 -3.22
2026-08-04 -3.54
2026-07-31 -3.22
2026-07-30 -3.36
2026-07-29 -3.18
2026-07-28 -3.22
2026-07-27 -3.36
2026-07-24 -3.43
2026-07-23 -3.39
2026-07-22 -3.57
2026-07-21 -3.57
2026-07-20 -3.61
2026-07-17 -3.75
2026-07-16 -3.64
2026-07-15 -3.75
2026-07-14 -3.93